NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.680
+0.040 (1.52%)
At close: Jun 2, 2025, 4:00 PM
2.720
+0.040 (1.49%)
After-hours: Jun 2, 2025, 7:51 PM EDT
NRx Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for NRx Pharmaceuticals stock ranges from a low of $18 to a high of $46. The average analyst price target of $28.5 forecasts a 963.43% increase in the stock price over the next year.
Price Target: $28.50 (+963.43%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NRx Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +1,056.72% | May 16, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +1,056.72% | Apr 30, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $45 → $46 | Strong Buy | Maintains | $45 → $46 | +1,616.42% | Apr 29, 2025 |
| BTIG | BTIG | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +571.64% | Apr 2, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +1,056.72% | Mar 31, 2025 |
Financial Forecast
Revenue This Year
n/a
from 1.20B
Revenue Next Year
n/a
EPS This Year
n/a
from -2.36
EPS Next Year
0.69
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 40.1M | 189.3M | 544.6M | ||
| Avg | 34.8M | 109.7M | 296.7M | ||
| Low | 29.4M | 41.6M | 61.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -96.7% | 444.2% | 396.4% | ||
| Avg | -97.1% | 215.4% | 170.5% | ||
| Low | -97.6% | 19.5% | -43.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.06 | 1.62 | 5.18 |
| Avg | - | 0.69 | 2.78 |
| Low | -0.06 | -0.01 | 0.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 650.0% |
| Avg | - | - | 302.7% |
| Low | - | - | -26.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.